Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Plos One|October 3, 2012
Lactase persistence and lipid pathway selection in the MaasaiKshitij Wagh, Aatish Bhatia, Gabriela Alexe, et al.Cancer Research Communications|June 28, 2023
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal CancerEsteban Terzo, Shruti A Apte, Simran Padhye, et al.Cell|June 16, 2009
Autophagy suppresses tumorigenesis through elimination of p62Robin Mathew, Cristina M Karp, Brian Beaudoin, et al.Hematological Oncology|August 14, 2019
PD-L1 expression is low in large B-cell lymphoma with MYC or double-hit translocationMette Vestergaard Elbaek, Mette Ølgod Pedersen, Marie Fredslund Breinholt, et al.Plos One|November 17, 2012
RAD001 enhances the potency of BEZ235 to inhibit mTOR signaling and tumor growthBeat Nyfeler, Yan Chen, Xiaoyan Li, et al.Cold Spring Harbor Perspectives in Medicine|March 11, 2020
Non-Hodgkin Lymphomas: Malignancies Arising from Mature B CellsJennifer Shingleton, Jie Wang, Carolyn Baloh, et al.The Oncologist|November 25, 2022
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic AdenocarcinomaPatrick M Grierson, Benjamin Tan, Katrina S Pedersen, et al.Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.NEJM Evidence|April 22, 2025
Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALSNeil A Shneider, Alex V Nesta, Olivia M Rifai, et al.Nature Communications|July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcomaJianguo Huang, Mark Chen, Melodi Javid Whitley, et al.Pageof 5